about
Stable gene targeting in human cells using single-strand oligonucleotides with modified basesTargeted In Situ Gene Correction of Dysfunctional APOE Alleles to Produce Atheroprotective Plasma ApoE3 Protein.Towards artificial metallonucleases for gene therapy: recent advances and new perspectives.Oligonucleotide-directed gene-editing technology: mechanisms and future prospects.Emerging gene editing strategies for Duchenne muscular dystrophy targeting stem cells.Oligonucleotide-mediated gene editing is underestimated in cells expressing mutated green fluorescent protein and is positively associated with target protein expression.
P2860
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Validation of oligonucleotide-mediated gene editing.
@en
Validation of oligonucleotide-mediated gene editing.
@nl
type
label
Validation of oligonucleotide-mediated gene editing.
@en
Validation of oligonucleotide-mediated gene editing.
@nl
prefLabel
Validation of oligonucleotide-mediated gene editing.
@en
Validation of oligonucleotide-mediated gene editing.
@nl
P2860
P356
P1433
P1476
Validation of oligonucleotide-mediated gene editing
@en
P2093
P2860
P2888
P304
P356
10.1038/GT.2009.32
P577
2009-04-02T00:00:00Z
P5875
P6179
1012111425